SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is facing significant downward pressure as investors express frustration over its long-term share performance, lack of management communication, and ongoing manipulation concerns. The community remains divided between those viewing the current price as a buying opportunity based on fundamentals and Orladeyo revenue, and those demoralized by perceived execution risks and looming competition.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSSI is trending as investors react to the company's role as a primary integration partner for Dell's AI server growth and the high-margin NVIDIA Vera Rubin architecture, though sentiment remains divided over its heavy customer concentration. While some traders view recent capacity expansions as a bullish signal for future revenue, others express skepticism regarding management's execution and the lack of new contract announcements.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is experiencing downward price pressure and increased volatility as investors react to a recent revenue miss and lowered full-year guidance, leading to debates over whether the stock is oversold given its strong direct-to-consumer margins and high cash position.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to concerns over surging oil prices driven by intensified conflict in the Middle East, specifically reports of pipeline attacks in Saudi Arabia and Houthi control in the Red Sea. While many traders cite supply constraints and geopolitical tension as justification for continued price gains, others express skepticism regarding the sustainability of the rally and caution against potential volatility.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending following a strong quarterly earnings report that beat expectations on revenue and ARR, leading several analysts to raise their price targets. Despite the positive results and high-profile partnerships, the stock has experienced significant volatility as traders debate its high valuation compared to peers and the impact of insider selling.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix shares are trending due to investor reaction following the company's announcement of subscription price increases in the UK and Germany. While some traders view the resulting pullback as a buying opportunity, others express frustration over the stock's volatility and skepticism regarding the company's growth strategy.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is trending as traders analyze its role in the energy infrastructure cycle, with significant debate surrounding recent volatility and the stock's position as a beneficiary of AI-driven power demand. While many in the community emphasize a long-term bullish outlook tied to a massive order backlog and grid modernization, others express frustration over recent price swings and skepticism regarding short-term momentum.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors monitor ongoing LNG supply constraints and geopolitical tensions in the Middle East, with many expressing frustration over persistent price action they attribute to market manipulation. Discussions remain focused on the company's long-term growth potential through facility expansion, despite concerns regarding debt, insider selling, and price volatility.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is currently the subject of intense community debate, with many traders speculating on the potential for upcoming institutional partnerships and infrastructure developments, such as the Onyx neobank and ISO 20022 compatibility. While some users express optimism about these technical catalysts, others dismiss the price action as a recurring pump-and-dump scheme and have voiced strong criticism regarding the lack of confirmed milestones and aggressive censorship in community channels.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing downward price pressure following a mixed clinical trial result for its PsA program, which the community perceives as failing to establish the drug as a clear 'best-in-class' candidate. Traders remain divided, with some expressing frustration over management's communication and recent dilution, while others argue the stock is significantly undervalued given the upcoming BLA submission for HS and a strong cash position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
